These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 28860488)
21. Newcastle Disease Virus Establishes Persistent Infection in Tumor Cells Rangaswamy US; Wang W; Cheng X; McTamney P; Carroll D; Jin H J Virol; 2017 Aug; 91(16):. PubMed ID: 28592535 [TBL] [Abstract][Full Text] [Related]
22. Characterization of temperature-sensitive HVJ (Sendai virus) infection in Vero cells: inhibitory mechanism of viral production at 41 degrees. Hirayama E; Ishida Y; Sugimoto M; Hiraki A; Kim J Intervirology; 2003; 46(2):86-95. PubMed ID: 12684547 [TBL] [Abstract][Full Text] [Related]
23. Gene transfection by quantitatively reconstituted Sendai envelope proteins into liposomes. Kim HS; Park YS Cancer Gene Ther; 2002 Feb; 9(2):173-7. PubMed ID: 11857035 [TBL] [Abstract][Full Text] [Related]
24. Optimised protocols to generate high titre lentiviral vectors using a novel transfection agent enabling extended HEK293T culture following transient transfection and suspension culture. Suleman S; Fawaz S; Roberts T; Ellison S; Bigger B; Themis M J Virol Methods; 2024 Apr; 325():114884. PubMed ID: 38218417 [TBL] [Abstract][Full Text] [Related]
25. Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection. Kuroda H; Kutner RH; Bazan NG; Reiser J J Virol Methods; 2009 May; 157(2):113-21. PubMed ID: 19114057 [TBL] [Abstract][Full Text] [Related]
26. Development of a scalable process for high-yield lentiviral vector production by transient transfection of HEK293 suspension cultures. Ansorge S; Lanthier S; Transfiguracion J; Durocher Y; Henry O; Kamen A J Gene Med; 2009 Oct; 11(10):868-76. PubMed ID: 19618482 [TBL] [Abstract][Full Text] [Related]
27. Roles of the highly conserved amino acids in the globular head and stalk region of the Newcastle disease virus HN protein in the membrane fusion process. Sun C; Wen H; Chen Y; Chu F; Lin B; Ren G; Song Y; Wang Z Biosci Trends; 2015 Feb; 9(1):56-64. PubMed ID: 25787910 [TBL] [Abstract][Full Text] [Related]
28. Development and Optimization of a High Titer Recombinant Lentivirus System. Storck A; Ludtke J; Kopp L; Juckem L Biotechniques; 2017 Sep; 63(3):136-138. PubMed ID: 28911318 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of Sendai virus hemagglutinin neuraminidase by the fusion protein. Dallocchio F; Tomasi M; Bellini T Biochem Biophys Res Commun; 1994 Jun; 201(2):988-93. PubMed ID: 8003040 [TBL] [Abstract][Full Text] [Related]
30. Sendai virus particle production: basic requirements and role of the SYWST motif present in HN cytoplasmic tail. Gosselin-Grenet AS; Mottet-Osman G; Roux L Virology; 2010 Sep; 405(2):439-47. PubMed ID: 20633915 [TBL] [Abstract][Full Text] [Related]
31. Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein. Porotto M; Murrell M; Greengard O; Doctor L; Moscona A J Virol; 2005 Feb; 79(4):2383-92. PubMed ID: 15681439 [TBL] [Abstract][Full Text] [Related]
32. Replacement of the ectodomains of the hemagglutinin-neuraminidase and fusion glycoproteins of recombinant parainfluenza virus type 3 (PIV3) with their counterparts from PIV2 yields attenuated PIV2 vaccine candidates. Tao T; Skiadopoulos MH; Davoodi F; Riggs JM; Collins PL; Murphy BR J Virol; 2000 Jul; 74(14):6448-58. PubMed ID: 10864657 [TBL] [Abstract][Full Text] [Related]
34. Naked Sendai virus vector lacking all of the envelope-related genes: reduced cytopathogenicity and immunogenicity. Yoshizaki M; Hironaka T; Iwasaki H; Ban H; Tokusumi Y; Iida A; Nagai Y; Hasegawa M; Inoue M J Gene Med; 2006 Sep; 8(9):1151-9. PubMed ID: 16841365 [TBL] [Abstract][Full Text] [Related]
35. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. Melanson VR; Iorio RM J Virol; 2006 Jan; 80(2):623-33. PubMed ID: 16378965 [TBL] [Abstract][Full Text] [Related]
36. Large-scale production of pseudotyped lentiviral vectors using baculovirus GP64. Kumar M; Bradow BP; Zimmerberg J Hum Gene Ther; 2003 Jan; 14(1):67-77. PubMed ID: 12573060 [TBL] [Abstract][Full Text] [Related]
37. Genetic Stability of Parainfluenza Virus 5-Vectored Human Respiratory Syncytial Virus Vaccine Candidates after Phan SI; Adam CM; Chen Z; Citron M; Liang X; Espeseth AS; Wang D; He B J Virol; 2017 Oct; 91(19):. PubMed ID: 28747497 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector. Wiegand M; Gori-Savellini G; Martorelli B; Bossow S; Neubert WJ; Cusi MG Vaccine; 2013 Aug; 31(37):3888-93. PubMed ID: 23831325 [TBL] [Abstract][Full Text] [Related]
39. Exploring nutrient supplementation and bioprocess optimization to improve the production of lentiviral vectors in serum-free medium suspension cultures. Vaz TA; Rodrigues AF; Coroadinha AS Biotechnol J; 2024 Jan; 19(1):e2300212. PubMed ID: 37903159 [TBL] [Abstract][Full Text] [Related]
40. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Paterson RG; Russell CJ; Lamb RA Virology; 2000 Apr; 270(1):17-30. PubMed ID: 10772976 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]